Heart disease gene linked to prostate cancer
...William B. Isaacs, Ph.D., professor of urology and oncology at the Brady Urological Institute and Kimmel Cancer Center at Johns Hopkins. Hunting for gene mutations that increase one's risk for prostate cancer, researchers screened 159 families with hereditary prostate cancer and found seven different mutatio...Study of manatee virus could help fight human cervical cancer
...dicine, and Dr. Partha Basu, head of gynecological oncology at the National Cancer Institute of India, a country that has very high rates of cervical cancer among its female population. Both doctors are experts in the field of human cervical cancer and are committed to a collaborative research project involvi...Stanford researchers switch off cancer gene; trick cells to self desruct
...said Dean Felsher, MD, PhD, assistant professor of oncology and lead researcher on the study. "Most people thought that cancer would come back once treatment that turned off an oncogene stopped." Felsher and his colleagues worked with a gene called MYC, which normally tells a cell when to grow or divide. In m...New drug shows promise in common and lethal form of leukemia
... Donald Small, M.D., Ph.D., associate professor of oncology at the Sidney Kimmel Comprehensive Cancer Center a...ns Mark Levis, M.D., Ph.D., assistant professor of oncology at the Hopkins Kimmel Cancer Center and the paper's first author. "By inhibiting the gene's ability...Radiation alone after surgery still the standard for head and neck cancer
...ients," says Arlene Forastiere, M.D., professor of oncology and otolaryngology at the Johns Hopkins Kimmel Cancer Center and medical oncology co-chair of the study. "Our current study shows that adding the chemotherapy drug cisplatin to stan...Hopkins researchers test new molecular marker for prostate cancer
...William B. Isaacs, Ph.D., professor of urology and oncology at the Brady Urological Institute and Kimmel Cancer Center* at Johns Hopkins, and senior author of this study. The Hopkins scientists caution that the link, if any, between increased expression of AMACR and eating beef and dairy foods is unclear and...Markers that can predict cancer spread could save women from unnecessary chemotherapy
...fessor in the department of radiation and cellular oncology at the University of Chicago, USA, said that patients with early breast cancer which has not spread to the lymph nodes (node-negative) are usually offered chemotherapy as a safety precaution, even though they have a 70-80% chance of being cured of th...Knocking out SHIP gene improves success of allogeneic bone marrow transplants in mice
...r the study. Dr. Kerr is an associate professor of oncology and biochemistry at USF and a member of Moffitt Ca...." said Karen Fields MD, professor of medicine and oncology at USF and director of the Bone Marrow Transplant Program at Moffitt Cancer Center. While graft-ver...Stool test for colon cancer reported by Kimmel Cancer Center at Johns Hopkins
...isease," says Kenneth Kinzler, Ph.D., professor of oncology at the Kimmel Cancer Center*. The investigators expect it will take an additional three to five years before the test will be available clinically. The new test is believed to be the first to reproducibly and reliably pinpoint colon cancer-linked AP...Blood stem cells carry targeted genes
... says Linzhao Cheng, Ph.D., assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center and director of the study. Using a gene known to produce a fluorescent protein, scientists transferred it into human adult and cord blood stem cells and injected the cells into immune-compromised mice. The ...Low doses of radiation in nature may pose more risk
... Led by professor of radiation oncology and public health Dr. Tom K. Hei, the study found that a dose that strikes as few as one in 10 cells has nearly the same mutagenic (mutation-causing) effect as a dose that strikes every cell. The added damage occurs, the researchers say, because of w...More chance of a cure for patients with common and aggressive form of blood cancer
...ausea). In the first nine months of 2001 the Roche oncology portfolio reached over 2 billion Swiss Francs in sales. With these innovative anti-cancer products and promising new drugs coming through the pipeline Roche expects to see strong growth in its Oncology Franchise in the future....Scientists using gene chips identify a unique form of leukemia
...ints. Armstrong, who is an instructor in pediatric oncology at Dana-Farber and Harvard Medical School, worked with Dana-Farbers Stanley Korsmeyer, MD, and Todd Golub, MD, on the project. Golub, who also is affiliated with the Whitehead Institute/MIT Center for Genome Research in Cambridge, is a pioneer in usi...Hopkins researchers develop potential new screening test for prostate cancer
...avid Sidransky, M.D., professor of otolaryngology, oncology and urology and director of the research. In the current study, Hopkins scientists used a technique called methylation-specific PCR to examine tissue samples from 69 patients with early-stage prostate cancer and 31 patients with benign prostate disea...Old drug shows promise for helping treat advanced lung cancer
...the division of hematology and oncology at Ohio State. "With the best treatment available - chemotherapy - we can increase one-year survival rates to about 35 percent. "We need to find something better than what we have for the ...Two separate controls regulate chromosome copying in yeast
...a postdoctoral fellow in the department of medical oncology and the department of molecular biology and genetics, which is part of the school's Institute for Basic Biomedical Sciences. "We can't yet link these two controller proteins in yeast or their human counterparts to cancer, but we do have a new genome ......enetics, said Randy Jirtle, professor of radiation oncology at Duke University Medical Center. Their own research using nuclear genes (genes from the nucleus or core of cells) has shown a nearly 100 percent statistical likelihood that the Duke results are correct. Mitochondria are the cell's power plants......aregivers. Campath, the newest product in Berlexs oncology portfolio, represents the most recent advance in C... therapy available to them. As a specialist in oncology drugs, ILEX is pleased to have played a key role in the clinical development of this new agent, said...Pooling worldwide data about childhood tumors helps researchers gauge aggressiveness of treatment
...ulticenter national cooperative group of pediatric oncology centers, will conduct a larger study of the tandem transplant protocol for high-risk neuroblastoma, with Dr. Grupp as the principal investigator. Pooling the Expertise of International Experts While Dr. Grupp works to refine treatments, Dr. Brodeurs ...Carnegie Mellon University receives $1 million to create biosensor tool kit
...pringboard to breakthroughs in fields ranging from oncology to tissue engineering."...